Goodman Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Goodman Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$766	Hold	6	–	–	﹤0.01%	178
2025 Q4	$732	Hold	6	–	–	﹤0.01%	180
2025 Q3	$601	Hold	6	–	–	﹤0.01%	180
2025 Q2	$498	Hold	6	–	–	﹤0.01%	143
2025 Q1	$487	Buy	+6	New	+$536	﹤0.01%	177
2024 Q4	–	Sell	-6	Closed	-$593	–	189
2024 Q3	$593	Hold	6	–	–	﹤0.01%	191
2024 Q2	$556	Sell	6 -7	-54%	-$628	﹤0.01%	172
2024 Q1	$1.23K	Hold	13	–	–	﹤0.01%	160
2023 Q4	$1.16K	Hold	13	–	–	﹤0.01%	143
2023 Q3	$949	Hold	13	–	–	﹤0.01%	147
2023 Q2	$1.08K	Hold	13	–	–	﹤0.01%	145
2023 Q1	$991	Hold	13	–	–	﹤0.01%	148
2022 Q4	$1K	Hold	13	–	–	﹤0.01%	140
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	157
2022 Q2	$1K	Buy	+13	New	+$976	﹤0.01%	169

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goodman Advisory Group's XBI Position: Q1 2026 in Review

Goodman Advisory Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 6 shares worth $766. The position accounts for ﹤0.01% of the portfolio, ranked #178.

Goodman Advisory Group first reported a position in XBI in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.23K in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Goodman Advisory Group held 6 shares of State Street SPDR S&P Biotech ETF worth $766 as of Q1 2026.
Goodman Advisory Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Goodman Advisory Group's portfolio in Q1 2026, its #178 holding.
Goodman Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 15 quarters since.
Goodman Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $1.23K in Q1 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.